[Robotic laparoscopic cystectomy: on the way to a standard procedure?].
Radical cystectomy is considered the standard treatment for muscle-invasive bladder cancer. Minimally invasive techniques - especially robot-assisted techniques (RARC) - are being increasingly employed for this indication. Herein, we evaluate the current status of RARC and its acceptance in the urological community. The field of RARC is steadily increasing particularly due to an extremely short learning curve for surgeons with previous experience in robot-assisted radical prostatectomy. Lymph node yield has been shown to be adequate in several independent studies, being comparable to that of the open approach. Urinary diversion is most frequently done extracorporeally while several groups have commited themselves to intracorporeal techniques and have already shown excellent results. The perioperative outcome data compare favourably to those of open cystectomy. Short-term and interim oncological data are promising while a final long-term assessment is still lacking. RARC completed by appropriate urinary diversion is gaining relevance in academic institutions worldwide. The relatively wide availability of the robotic system will further add to this development. Secondary to the final assessment of its oncological efficacy RARC has the potential to become a standard treatment of muscle-invasive bladder cancer since its perioperative efficacy is excellent.